Week in Review: Paving the Way for Innovative Medicines

Paving the Way for Innovative Medicines

07.19.13 | By

The biopharmaceutical community has made tremendous progress in recent years developing innovative treatments for chronic conditions, thanks to advancements in science and medicine.  Not only do these advancements improve people’s lives every day, they also provide hope that we may one day be able to prevent or cure diseases like Alzheimer’s, cancer and HIV/AIDS.  This week, the Catalyst addressed a number of these advances and highlighted the importance of continued innovation.

Did you think time was the only cure for a broken heart? Maybe not, according to an article in Everyday Health. Researchers at the Mayo Clinic are training bone marrow stem cells to become heart cells by treating them with proteins that trigger heart development. Similar advancements are being made with Alzheimer’s disease. Clinical trials are quickly enhancing our understanding of this complex disease, and there are now more than 100 potential new medicines in development to treat Alzheimer’s.

To continue these important advancements, there needs to be an environment that fosters innovation and continued investment in research and development. Strong intellectual property protections both in the U.S. and abroad are essential. Given the Trans-Pacific Partnership (TPP) negotiations this week, our “Conversation” forum specifically addressed this issue.

We are always excited to hear what the future might hold for patients. To learn more about innovation and new medicines in the pipeline, be sure to check back in the coming weeks for the launch of our new Medicines in Development Report on neurological disorders.


Hide Comments

More On PhRMA — powered by PhRMApedia


Cost in Context